Cargando…

Histamine Intolerance—The More We Know the Less We Know. A Review

The intake of food may be an initiator of adverse reactions. Food intolerance is an abnormal non-immunological response of the organism to the ingestion of food or its components in a dosage normally tolerated. Despite the fact that food intolerance is spread throughout the world, its diagnosing is...

Descripción completa

Detalles Bibliográficos
Autores principales: Hrubisko, Martin, Danis, Radoslav, Huorka, Martin, Wawruch, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308327/
https://www.ncbi.nlm.nih.gov/pubmed/34209583
http://dx.doi.org/10.3390/nu13072228
_version_ 1783728254576754688
author Hrubisko, Martin
Danis, Radoslav
Huorka, Martin
Wawruch, Martin
author_facet Hrubisko, Martin
Danis, Radoslav
Huorka, Martin
Wawruch, Martin
author_sort Hrubisko, Martin
collection PubMed
description The intake of food may be an initiator of adverse reactions. Food intolerance is an abnormal non-immunological response of the organism to the ingestion of food or its components in a dosage normally tolerated. Despite the fact that food intolerance is spread throughout the world, its diagnosing is still difficult. Histamine intolerance (HIT) is the term for that type of food intolerance which includes a set of undesirable reactions as a result of accumulated or ingested histamine. Manifestations may be caused by various pathophysiological mechanisms or a combination of them. The problem with a “diagnosis” of HIT is precisely the inconstancy and variety of the manifestations in the same individual following similar stimuli. The diagnosing of HIT therefore requires a complex time-demanding multidisciplinary approach, including the systematic elimination of disorders with a similar manifestation of symptoms. Among therapeutic approaches, the gold standard is a low-histamine diet. A good response to such a diet is considered to be confirmation of HIT. Alongside the dietary measures, DAO supplementation supporting the degradation of ingested histamine may be considered as subsidiary treatment for individuals with intestinal DAO deficiency. If antihistamines are indicated, the treatment should be conscious and time-limited, while 2nd or 3rd generation of H(1) antihistamines should take precedence.
format Online
Article
Text
id pubmed-8308327
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83083272021-07-25 Histamine Intolerance—The More We Know the Less We Know. A Review Hrubisko, Martin Danis, Radoslav Huorka, Martin Wawruch, Martin Nutrients Review The intake of food may be an initiator of adverse reactions. Food intolerance is an abnormal non-immunological response of the organism to the ingestion of food or its components in a dosage normally tolerated. Despite the fact that food intolerance is spread throughout the world, its diagnosing is still difficult. Histamine intolerance (HIT) is the term for that type of food intolerance which includes a set of undesirable reactions as a result of accumulated or ingested histamine. Manifestations may be caused by various pathophysiological mechanisms or a combination of them. The problem with a “diagnosis” of HIT is precisely the inconstancy and variety of the manifestations in the same individual following similar stimuli. The diagnosing of HIT therefore requires a complex time-demanding multidisciplinary approach, including the systematic elimination of disorders with a similar manifestation of symptoms. Among therapeutic approaches, the gold standard is a low-histamine diet. A good response to such a diet is considered to be confirmation of HIT. Alongside the dietary measures, DAO supplementation supporting the degradation of ingested histamine may be considered as subsidiary treatment for individuals with intestinal DAO deficiency. If antihistamines are indicated, the treatment should be conscious and time-limited, while 2nd or 3rd generation of H(1) antihistamines should take precedence. MDPI 2021-06-29 /pmc/articles/PMC8308327/ /pubmed/34209583 http://dx.doi.org/10.3390/nu13072228 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hrubisko, Martin
Danis, Radoslav
Huorka, Martin
Wawruch, Martin
Histamine Intolerance—The More We Know the Less We Know. A Review
title Histamine Intolerance—The More We Know the Less We Know. A Review
title_full Histamine Intolerance—The More We Know the Less We Know. A Review
title_fullStr Histamine Intolerance—The More We Know the Less We Know. A Review
title_full_unstemmed Histamine Intolerance—The More We Know the Less We Know. A Review
title_short Histamine Intolerance—The More We Know the Less We Know. A Review
title_sort histamine intolerance—the more we know the less we know. a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308327/
https://www.ncbi.nlm.nih.gov/pubmed/34209583
http://dx.doi.org/10.3390/nu13072228
work_keys_str_mv AT hrubiskomartin histamineintolerancethemoreweknowthelessweknowareview
AT danisradoslav histamineintolerancethemoreweknowthelessweknowareview
AT huorkamartin histamineintolerancethemoreweknowthelessweknowareview
AT wawruchmartin histamineintolerancethemoreweknowthelessweknowareview